Shagun Singh
Stock Analyst at RBC Capital
(2.39)
# 2,541
Out of 5,242 analysts
259
Total ratings
44.44%
Success rate
-1.36%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Outperform | $115 → $120 | $79.93 | +50.13% | 10 | May 8, 2026 | |
| TFX Teleflex | Upgrades: Outperform | $135 → $155 | $132.74 | +16.77% | 25 | May 8, 2026 | |
| PODD Insulet | Maintains: Outperform | $325 → $280 | $154.61 | +81.10% | 5 | May 7, 2026 | |
| INSP Inspire Medical Systems | Maintains: Sector Perform | $56 → $45 | $42.53 | +5.81% | 11 | May 5, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $105 → $100 | $56.81 | +76.03% | 21 | Apr 23, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $135 → $130 | $88.82 | +46.36% | 19 | Apr 17, 2026 | |
| JNJ Johnson & Johnson | Reiterates: Outperform | $255 | $230.00 | +10.87% | 25 | Mar 30, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $210 → $172 | $146.95 | +17.05% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $326.55 | +14.53% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $441.58 | +47.20% | 18 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $82.16 | +21.71% | 24 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $78.58 | +50.17% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $3.86 | +340.41% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $86.08 | +17.33% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $66.95 | +26.96% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $13.86 | +80.38% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $317.75 | +36.90% | 19 | Jan 29, 2025 |
Globus Medical
May 8, 2026
Maintains: Outperform
Price Target: $115 → $120
Current: $79.93
Upside: +50.13%
Teleflex
May 8, 2026
Upgrades: Outperform
Price Target: $135 → $155
Current: $132.74
Upside: +16.77%
Insulet
May 7, 2026
Maintains: Outperform
Price Target: $325 → $280
Current: $154.61
Upside: +81.10%
Inspire Medical Systems
May 5, 2026
Maintains: Sector Perform
Price Target: $56 → $45
Current: $42.53
Upside: +5.81%
Boston Scientific
Apr 23, 2026
Maintains: Outperform
Price Target: $105 → $100
Current: $56.81
Upside: +76.03%
Abbott Laboratories
Apr 17, 2026
Maintains: Outperform
Price Target: $135 → $130
Current: $88.82
Upside: +46.36%
Johnson & Johnson
Mar 30, 2026
Reiterates: Outperform
Price Target: $255
Current: $230.00
Upside: +10.87%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Sector Perform
Price Target: $210 → $172
Current: $146.95
Upside: +17.05%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $326.55
Upside: +14.53%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $441.58
Upside: +47.20%
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $82.16
Upside: +21.71%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $78.58
Upside: +50.17%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $3.86
Upside: +340.41%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $86.08
Upside: +17.33%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $66.95
Upside: +26.96%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $13.86
Upside: +80.38%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $317.75
Upside: +36.90%